UBS Group AG - KINDRED BIOSCIENCES INC ownership

KINDRED BIOSCIENCES INC's ticker is KIN and the CUSIP is 494577109. A total of 83 filers reported holding KINDRED BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 2.08 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of KINDRED BIOSCIENCES INC
ValueSharesWeighting
Q2 2021$593,000
+44.3%
64,750
-21.7%
0.00%
Q1 2021$411,000
+26.5%
82,685
+9.5%
0.00%
Q4 2020$325,000
-10.0%
75,536
-10.3%
0.00%
Q3 2020$361,000
-37.7%
84,236
-34.6%
0.00%
Q2 2020$579,000
+18.9%
128,885
+5.9%
0.00%
Q1 2020$487,000
-60.1%
121,741
-15.5%
0.00%
Q4 2019$1,222,000
+47.8%
144,079
+19.3%
0.00%
Q3 2019$827,000
+22.7%
120,817
+49.4%
0.00%
Q2 2019$674,000
+3.2%
80,859
+13.5%
0.00%
Q1 2019$653,000
-25.4%
71,259
-10.8%
0.00%
Q4 2018$875,000
+0.9%
79,910
+28.6%
0.00%
Q3 2018$867,000
+49.0%
62,146
+13.9%
0.00%
Q2 2018$582,000
+46.2%
54,574
+18.5%
0.00%
Q1 2018$398,000
-11.0%
46,044
-2.6%
0.00%
Q4 2017$447,000
+20.2%
47,259
-0.3%
0.00%
Q3 2017$372,000
-35.0%
47,412
-28.8%
0.00%
Q2 2017$572,000
+24.3%
66,595
+2.1%
0.00%
Q1 2017$460,000
+318.2%
65,217
+152.7%
0.00%
Q4 2016$110,000
-27.6%
25,806
-15.3%
0.00%
Q3 2016$152,000
+52.0%
30,484
+7.8%
0.00%
Q2 2016$100,000
+23.5%
28,281
+20.2%
0.00%
Q1 2016$81,000
+22.7%
23,536
+22.0%
0.00%
Q4 2015$66,000
-13.2%
19,285
+31.7%
0.00%
Q3 2015$76,000
+72.7%
14,647
+128.6%
0.00%
Q2 2015$44,000
+41.9%
6,407
+47.4%
0.00%
Q1 2015$31,000
-38.0%
4,347
-34.9%
0.00%
Q4 2014$50,0006,6820.00%
Other shareholders
KINDRED BIOSCIENCES INC shareholders Q4 2020
NameSharesValueWeighting ↓
Park West Asset Management LLC 6,628,757$28,570,0000.59%
SILVERBACK ASSET MANAGEMENT LLC 611,364$2,635,0000.34%
GENERAL AMERICAN INVESTORS CO INC 300,000$1,293,0000.13%
Ariel Investments 1,928,976$8,314,0000.09%
Granahan Investment Management 752,822$3,245,0000.07%
DCF Advisers, LLC 40,000$172,0000.07%
CIM INVESTMENT MANAGEMENT INC 37,754$163,0000.05%
Anson Funds Management LP 57,277$247,0000.05%
PARK CIRCLE Co 6,300$27,0000.03%
NJ State Employees Deferred Compensation Plan 32,000$138,0000.02%
View complete list of KINDRED BIOSCIENCES INC shareholders